A 67-year-old man with symptomatic PAD and no revascularization in the last year asks about rivaroxaban use. What antithrombotic regimen is supported ...

Question

A 67-year-old man with symptomatic PAD and no revascularization in the last year asks about rivaroxaban use. What antithrombotic regimen is supported for reduction of MACE/MALE?

Accepted Answer

Low-dose rivaroxaban 2.5 mg twice daily plus aspirin if bleeding risk acceptable

Answer

Full-dose rivaroxaban 20 mg daily monotherapy

Answer

Dual antiplatelet therapy indefinitely

Answer

Aspirin 325 mg daily only

Answer

Warfarin with INR 2-3

PAD - dual pathway inhibition MCQ (SBA): Peripheral Artery Disease

A 67-year-old man with symptomatic PAD and no revascularization in the last year asks about rivaroxaban use. What antithrombotic regimen is supported for reduction of MACE/MALE?